Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

UBA7 Antikörper

UBA7 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 5B10 unconjugated
Produktnummer ABIN969450
  • Target Alle UBA7 Antikörper anzeigen
    UBA7 (Ubiquitin-Like Modifier Activating Enzyme 7 (UBA7))
    Reaktivität
    • 51
    • 2
    • 2
    Human
    Wirt
    • 52
    • 3
    Maus
    Klonalität
    • 55
    Monoklonal
    Konjugat
    • 21
    • 5
    • 4
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser UBA7 Antikörper ist unkonjugiert
    Applikation
    • 28
    • 20
    • 20
    • 13
    • 13
    • 7
    • 4
    • 3
    • 3
    • 1
    Western Blotting (WB), ELISA
    Aufreinigung
    purified
    Immunogen
    Purified recombinant fragment of human UBE1L expressed in E. coli.
    Klon
    5B10
    Isotyp
    IgG1
    Top Product
    Discover our top product UBA7 Primärantikörper
  • Applikationshinweise
    ELISA: 1:10000, WB: 1:500 - 1:2000
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    Ascitic fluid containing 0.03 % sodium azide.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C/-20 °C
    Informationen zur Lagerung
    4°C, -20°C for long term storage
  • Kitareewan, Pitha-Rowe, Sekula, Lowrey, Nemeth, Golub, Freemantle, Dmitrovsky: "UBE1L is a retinoid target that triggers PML/RARalpha degradation and apoptosis in acute promyelocytic leukemia." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 99, Issue 6, pp. 3806-11, (2002) (PubMed).

    Carritt, Kok, van den Berg, Osinga, Pilz, Hofstra, Davis, van der Veen, Rabbitts, Gulati: "A gene from human chromosome region 3p21 with reduced expression in small cell lung cancer." in: Cancer research, Vol. 52, Issue 6, pp. 1536-41, (1992) (PubMed).

  • Target
    UBA7 (Ubiquitin-Like Modifier Activating Enzyme 7 (UBA7))
    Andere Bezeichnung
    UBE1L (UBA7 Produkte)
    Synonyme
    D8 antikoerper, UBA1B antikoerper, UBE1L antikoerper, UBE2 antikoerper, Ube1l antikoerper, 1300004C08Rik antikoerper, UBE1 antikoerper, xubc3 antikoerper, ubiquitin like modifier activating enzyme 7 antikoerper, ubiquitin-like modifier activating enzyme 7 antikoerper, ubiquitin conjugating enzyme E2 R2 S homeolog antikoerper, ubiquitin-like modifier-activating enzyme 7 antikoerper, UBA7 antikoerper, Uba7 antikoerper, ube2r2.S antikoerper, LOC100092397 antikoerper
    Hintergrund

    Description: The modification of proteins with ubiquitin is an important cellular mechanism for targeting.Tissue specificity: Expressed in a variety of normal and tumor cell types, but is reduced in lung cancer cell lines abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes, or E1s, ubiquitin-conjugating enzymes, or E2s, and ubiquitin-protein ligases, or E3s. This gene encodes a member of the E1 ubiquitin-activating enzyme family. The encoded enzyme is a retinoid target that triggers promyelocytic leukemia (PML)/retinoic acid receptor alpha (RARalpha) degradation and apoptosis in acute promyelocytic leukemia, where it is involved in the conjugation of the ubiquitin-like interferon-stimulated gene 15 protein.

    Aliases: D8, UBE2, UBA1B, UBE1L, MGC12713, UBA7

    Molekulargewicht
    112 kDa
    Gen-ID
    7318
    HGNC
    7318
Sie sind hier:
Kundenservice